Literature DB >> 2157214

cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases.

T C Boone1, M J Johnson, Y A De Clerck, K E Langley.   

Abstract

The purification and characterization of a metalloproteinase inhibitor (MI) from bovine aortic endothelial cells, and the demonstration that it is related to, but distinct from, tissue inhibitor of metalloproteinase (TIMP), have previously been reported [De Clerck, Y. A., Yean, T.-D., Ratzkin, B. J., Lu, H.S. & Langley, K. E. (1989) J. Biol. Chem. 264, 17445-17453]. The cDNA cloning of the bovine MI and its human homolog is now reported. The bovine cDNA cloning used probes designed on the basis of NH2-terminal amino acid sequence of bovine MI. The human cDNA cloning in turn used probes representing parts of the bovine cDNA nucleotide sequence. Both cDNAs encode leader sequences of 26 amino acids and mature protein sequences of 194 amino acids. The amino acid sequences of the mature proteins are 94% identical. The human MI cDNA was expressed in Escherichia coli, and a preparation containing anticollagenase activity was recovered. The amino acid sequence of mature human MI is 38% identical to the sequence for human TIMP, and the 12 cysteines in MI and TIMP are aligned almost identically. Thus MI and TIMP comprise an inhibitor family.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157214      PMCID: PMC53778          DOI: 10.1073/pnas.87.7.2800

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Collagenase inhibition by cationic proteins derived from cartilage and aorta.

Authors:  K E Kuettner; J Hiti; R Eisenstein; E Harper
Journal:  Biochem Biophys Res Commun       Date:  1976-09-07       Impact factor: 3.575

2.  Sequence at the 3' end of globin mRNA shows homology with immunoglobulin light chain mRNA.

Authors:  N J Proudfoot; G G Brownlee
Journal:  Nature       Date:  1974-11-29       Impact factor: 49.962

3.  Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity.

Authors:  J H Morrissey
Journal:  Anal Biochem       Date:  1981-11-01       Impact factor: 3.365

4.  Effect of natural protease inhibitors and a chemoattractant on tumor cell invasion in vitro.

Authors:  U P Thorgeirsson; L A Liotta; T Kalebic; I M Margulies; K Thomas; M Rios-Candelore; R G Russo
Journal:  J Natl Cancer Inst       Date:  1982-11       Impact factor: 13.506

5.  A quantitative collagen film collagenase assay for large numbers of samples.

Authors:  B Johnson-Wint
Journal:  Anal Biochem       Date:  1980-05-01       Impact factor: 3.365

6.  A membrane-filter technique for the detection of complementary DNA.

Authors:  D T Denhardt
Journal:  Biochem Biophys Res Commun       Date:  1966-06-13       Impact factor: 3.575

7.  Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2.

Authors:  G I Goldberg; B L Marmer; G A Grant; A Z Eisen; S Wilhelm; C S He
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases.

Authors:  G Murphy; T E Cawston; J J Reynolds
Journal:  Biochem J       Date:  1981-04-01       Impact factor: 3.857

Review 10.  Extracellular matrix.

Authors:  E D Hay
Journal:  J Cell Biol       Date:  1981-12       Impact factor: 10.539

View more
  32 in total

1.  Stromelysin-1 (MMP-3) is a target and a regulator of Wnt1-induced epithelial-mesenchymal transition (EMT).

Authors:  Laurence Blavier; Alisa Lazaryev; Xiang-He Shi; Frederick J Dorey; Gregory M Shackleford; Yves A DeClerck
Journal:  Cancer Biol Ther       Date:  2010-07-29       Impact factor: 4.742

2.  The architecture of cancer.

Authors:  J Waxman; H Wasan
Journal:  BMJ       Date:  1992-11-28

3.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

4.  Programmed cell death (apoptosis) in cord blood lymphocytes.

Authors:  S Aggarwal; A Gupta; S Nagata; S Gupta
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

5.  TIMP-2 is required for efficient activation of proMMP-2 in vivo.

Authors:  Z Wang; R Juttermann; P D Soloway
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

6.  Expression of matrix metalloproteinases in human glioma cell lines in the presence of IL-10.

Authors:  S Wagner; C Stegen; H Bouterfa; C Huettner; S Kerkau; W Roggendorf; K Roosen; J C Tonn
Journal:  J Neurooncol       Date:  1998-11       Impact factor: 4.130

7.  Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.

Authors:  C Fernandez-Catalan; W Bode; R Huber; D Turk; J J Calvete; A Lichte; H Tschesche; K Maskos
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

Review 8.  Matrix degrading metalloproteinases.

Authors:  B W Ennis; L M Matrisian
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  Identification of tissue inhibitor of metalloproteinase-2 (TIMP-2)-progelatinase complex as the third metalloproteinase inhibitor peak in rheumatoid synovial fluid.

Authors:  T E Cawston; H F Bigg; I M Clark; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

10.  The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells.

Authors:  M Shingu; Y Nagai; T Isayama; T Naono; M Nobunaga; Y Nagai
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.